BDNF and Anxiety: On day 14 of therapy, patients homozygous for the minor allele rs7124442*CC of BDNF had higher scores for the severity of anxiety symptoms (14.5 (9.25:19.5)), assessed by the HARS, and typical depressive symptoms (13 (10.25:15.75)), assessed by the SIGH-SAD scale, compared to carriers of the CT (7 (4.5:12.5) and 9 (5.25:12), respectively) and TT (10 (7:15) and 11 (8:14), respectively) genotypes (p = 0.008 and p = 0.019).